StocksCompany news· Sep 24
McDonald's Faces Consumer Discretionary Weakness
McDonald's shares declined nearly 5% on September 24, amid broader consumer discretionary sector struggles and inflation concerns.
Read the full story →From the archiveRead today's paper →
Thursday Sep 24, 2026
StocksCompany news· Sep 24
McDonald's shares declined nearly 5% on September 24, amid broader consumer discretionary sector struggles and inflation concerns.
Read the full story →Cracker Barrel (CBRL) shares rose 5.99% on September 24 after the company reported stronger-than-expected fourth-quarter earnings. Despite a decline in revenue, the adjusted profit increase suggests improved operational efficiency. The company's focus on upgrading menu items appears to resonate with customers, aligning with its strategy to enhance dining experiences and drive sales growth.
Royal Caribbean Cruises Ltd. (RCL) announced a $3 billion transaction on September 24, expanding its partnership with Sandals Resorts. This strategic move aims to diversify its offerings and capture a larger share of the luxury travel market. The deal underscores Royal Caribbean's commitment to growth and innovation in the competitive travel services sector.
Tesla (TSLA) remains under scrutiny as its Full Self-Driving system faces criticism for safety issues identified in a Belgium test. This ongoing regulatory challenge comes as Tesla seeks to maintain its leadership in the electric vehicle market. The NHTSA's open investigation adds pressure, with potential implications for Tesla's expansion plans.
MarketsMarkets today· Sep 24
U.S. equities declined on September 24, with the Nasdaq dropping 1.13% as stronger business-activity data pushed yields higher, pressuring growth stocks.
Read the full story →Technology stocks faced headwinds on September 24, with the sector declining 0.82%. Rising Treasury yields have dampened investor appetite for long-duration growth assets, as higher rates increase the cost of capital and compress valuation multiples. This environment poses challenges for tech companies reliant on future earnings growth.
Consumer discretionary stocks, including McDonald's, struggled on September 24, declining 0.8%. Inflationary pressures and rising yields have constrained consumer spending power, prompting a reevaluation of growth prospects within the sector. This trend highlights the sensitivity of discretionary companies to macroeconomic fluctuations.
Basic materials emerged as a rare bright spot on September 24, gaining 1.11%. The sector's defensive characteristics and exposure to inflationary assets have attracted investor interest amid broader market volatility. Companies within this segment could benefit from sustained demand for raw materials and commodities.
BondsRates and credit· Sep 24
U.S. Treasury yields surged on September 24, with the 10-year yield reaching its highest level since 2007, driven by strong U.S. PMI data.
Read the full story →The U.S. two-year Treasury yield climbed to 4.90% on September 24, reaching a new two-year high. This increase underscores market expectations of continued Federal Reserve interest rate hikes, as strong economic data bolsters the case for tighter monetary policy. The two-year yield's sensitivity to policy changes makes it a critical gauge for short-term interest rate expectations.
On September 24, global bond markets exhibited divergent yield trends, with U.S., Japanese, and Australian long-term yields rising in tandem. This simultaneous increase reflects a global reassessment of monetary policy trajectories amid persistent inflationary pressures. The coordinated yield movements suggest that central banks may face similar challenges in managing inflation and economic growth.
Credit markets are grappling with the implications of rising yields and tightening monetary policy on September 24. Higher borrowing costs could strain corporate balance sheets, particularly for companies with significant debt loads. As yields rise, the cost of refinancing and new issuance may increase, prompting a reevaluation of credit risk across sectors.
GeopoliticsWorld and markets· Sep 24
Oil prices eased on September 24 amid trade and peace talks, while geopolitical risks remain a key concern for markets.
Read the full story →The U.S. dollar's strength on September 24 has placed pressure on several global currencies. The Brazilian real and the offshore yuan both weakened, while the yen strengthened slightly despite Japan's record-high long-term yields. The dollar's rally reflects investor confidence in the U.S. economy amid rising yields and potential Fed rate hikes.
European equity markets faced pressure on September 24 as rising global yields weighed on investor sentiment. Euro Stoxx 50 futures fell 0.4%, reflecting concerns over the impact of higher borrowing costs on corporate earnings. The reassessment of European and U.S. rate paths continues to shape market outlooks.
Inflation concerns are weighing on Indian equities, with rising energy prices exacerbating cost pressures. The impact of higher fuel costs on consumer spending and industrial output remains a central challenge for the Indian economy. Policymakers are grappling with balancing growth and inflation amid a complex global environment.
MemesSpeculation watch· Sep 24
Wheeler Real Estate Investment Trust surged 210% on September 24 after a reverse stock split, drawing speculative interest.
Read the full story →Beneficient (BENF) surged 399% on September 24, becoming a major player in retail trading activity. The significant price increase has drawn attention from individual investors seeking quick gains. However, the volatility associated with such movements underscores the speculative nature of retail trading in microcap stocks.
Artelo Biosciences (ARTL) experienced a 76.14% increase in its stock price on September 24. The surge reflects heightened speculative interest in the biotech sector, though the underlying reasons for the move remain unclear. Such price movements can attract momentum traders, leading to increased volatility.
Jaguar Health (JAGX) saw its shares plummet 74.14% on September 24, marking one of the steepest declines in the market. The dramatic drop highlights the risks inherent in biotech investing, where clinical setbacks or financial challenges can lead to significant valuation losses.